Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical relevance and functional implications for human leucocyte antigen‐g expression in non‐small‐cell lung cancer
Aifen Lin, Chengsong Zhu, H.‐X. Chen, et al.
Journal of Cellular and Molecular Medicine (2009) Vol. 14, Iss. 9, pp. 2318-2329
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

HLA-G
Edgardo D. Carosella, Nathalie Rouas‐Freiss, Diana Tronik‐Le Roux, et al.
Advances in immunology (2015), pp. 33-144
Closed Access | Times Cited: 341
The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer
Roy M. Bremnes, Khalid Al‐Shibli, Tom Dønnem, et al.
Journal of Thoracic Oncology (2010) Vol. 6, Iss. 4, pp. 824-833
Open Access | Times Cited: 312
NK Cell-Based Immune Checkpoint Inhibition
Muhammad Khan, Sumbal Arooj, Hua Wang
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 276
Comparative analysis of the tumor immune-microenvironment of primary and brain metastases of non-small-cell lung cancer reveals organ-specific and EGFR mutation-dependent unique immune landscape
Seung Geun Song, Sehui Kim, Jaemoon Koh, et al.
Cancer Immunology Immunotherapy (2021) Vol. 70, Iss. 7, pp. 2035-2048
Closed Access | Times Cited: 113
The immunosuppressive molecule HLA-G and its clinical implications
Álvaro González, Vera Rebmann, Joël LeMaoult, et al.
Critical Reviews in Clinical Laboratory Sciences (2012) Vol. 49, Iss. 3, pp. 63-84
Closed Access | Times Cited: 190
Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
Laurence Amiot, Soldano Ferrone, Hans Grosse‐Wilde, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 417-431
Open Access | Times Cited: 133
Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges
Aifen Lin, Wei‐Hua Yan
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 121
Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy
Aifen Lin, Wei‐Hua Yan
Molecular Medicine (2015) Vol. 21, Iss. 1, pp. 782-791
Open Access | Times Cited: 120
Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects
Siyuan Wang, Jiaxin Wang, Yu Xia, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Melanoma cells become resistant to NK‐cell‐mediated killing when exposed to NK‐cell numbers compatible with NK‐cell infiltration in the tumor
Mirna Balsamo, William Vermi, Monica Parodi, et al.
European Journal of Immunology (2012) Vol. 42, Iss. 7, pp. 1833-1842
Closed Access | Times Cited: 104
Update on Immune Checkpoint Inhibitors in Lung Cancer
Ben Creelan
Cancer Control (2014) Vol. 21, Iss. 1, pp. 80-89
Open Access | Times Cited: 78
The Role of HLA-G Molecule and HLA-G Gene Polymorphisms in Tumors, Viral Hepatitis, and Parasitic Diseases
Fabrício C. Dias, Erick C. Castelli, Cristhianna V. A. Collares, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 71
CD8+PD-1–ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-G
Clément Dumont, Alix Jacquier, Jérôme Verine, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 10, pp. 1619-1632
Open Access | Times Cited: 62
HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
Aifen Lin, Wei‐Hua Yan
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 45
Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: An unexpected prognostic significance?
Leoš Křen, Ondřej Slabý, Katarína Múčková, et al.
Neuropathology (2010) Vol. 31, Iss. 2, pp. 129-134
Closed Access | Times Cited: 82
Human leukocyte antigen‐G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells
Lutao Du, Xiaoyan Xiao, Chuanxin Wang, et al.
Cancer Science (2011) Vol. 102, Iss. 7, pp. 1272-1280
Open Access | Times Cited: 76
Upregulation of human leukocyte antigen–G expression and its clinical significance in ductal breast cancer
Haixiao Chen, Aifen Lin, Chao-Jun Shen, et al.
Human Immunology (2010) Vol. 71, Iss. 9, pp. 892-898
Closed Access | Times Cited: 71
Human leukocyte antigen-G (HLA-G) expression in cervical cancer lesions is associated with disease progression
Xiang-Juan Li, Xia Zhang, Aifen Lin, et al.
Human Immunology (2012) Vol. 73, Iss. 9, pp. 946-949
Closed Access | Times Cited: 66
Prognostic relevance of soluble human leukocyte antigen–G and total human leukocyte antigen class I molecules in lung cancer patients
Philipp Schütt, Birgit Schütt, Magdalena Switala, et al.
Human Immunology (2010) Vol. 71, Iss. 5, pp. 489-495
Closed Access | Times Cited: 66
Human leukocyte antigen‐G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma
Aifen Lin, Xia Zhang, Wenjun Zhou, et al.
International Journal of Cancer (2010) Vol. 129, Iss. 6, pp. 1382-1390
Open Access | Times Cited: 58
Human leukocyte antigen-G in cancer: Are they clinically relevant?
Wei‐Hua Yan
Cancer Letters (2011) Vol. 311, Iss. 2, pp. 123-130
Closed Access | Times Cited: 58
Integrative HLA typing of tumor and adjacent normal tissue can reveal insights into the tumor immune response
Angelina Sverchkova, Scott Burkholz, Reid Rubsamen, et al.
BMC Medical Genomics (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Human leukocyte antigen (HLA)-G and cervical cancer immunoediting: A candidate molecule for therapeutic intervention and prognostic biomarker?
Fabrícia Gimenes, Jorge Juarez Vieira Teixeira, André Luelsdorf Pimenta de Abreu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2014) Vol. 1846, Iss. 2, pp. 576-589
Closed Access | Times Cited: 35
Co-expression of ILT4/HLA-G in human non-small cell lung cancer correlates with poor prognosis and ILT4-HLA-G interaction activates ERK signaling
Yi Zhang, Jianqiang Zhao, Lijun Qiu, et al.
Tumor Biology (2016) Vol. 37, Iss. 8, pp. 11187-11198
Closed Access | Times Cited: 34
Predicting the most deleterious missense nsSNPs of the protein isoforms of the human HLA-G gene and in silico evaluation of their structural and functional consequences
Elaheh Emadi, Fatemeh Akhoundi, Seyed Mehdi Kalantar, et al.
BMC Genomic Data (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top